According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings (TTM) are -NZ$34.98 M. In 2023 the company made an earning of -NZ$18.75 M an increase over its 2022 earnings that were of -NZ$32.15 M.The earnings displayed on this page is the company's Pretax Income.